Matinas BioPharma Holdings, Inc. (MTNB)
NYSE: MTNB · Pharmaceutical Preparations · Bedminster, NJ · filing with the SEC since 2013
Filings
258 filings since 2017 beside 232 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company
10-Q
Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Nov 14, 2026
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed May 12, 2025.
Filings a yearinsider forms included
6872543339235831
2026 counts to Nov 13, 2026.
Listing warning from its exchange (8-K item 3.01): 4 times in the last 36 months, the newest Sep 4, 2026.Officer or director change (8-K item 5.02): 15 times in the last 36 months, the newest Jul 13, 2026.SEC letters: 2 in the last 36 months, the newest Apr 28, 2025.A late-filing notice, Form NT 10-K, filed Mar 31, 2025.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Sep 28, 2026
8-K items 3.03, 5.03, 9.01
Change to shareholders' rights; Charter, bylaw or fiscal-year change · Current report
Sep 25, 2026
Sep 4, 2026
8-K items 3.01, 8.01, 9.01
Listing warning from its exchange; Other event · Current report
Aug 31, 2026
Jul 13, 2026
8-K items 1.01, 3.02, 3.03, 5.01, 5.02, 5.03, 7.01, 8.01, 9.01
Major agreement signed; Shares sold without registration; Change to shareholders' rights; Change of control; Officer or director change; Charter, bylaw or fiscal-year change; Investor disclosure (Regulation FD); Other event · Current report
Jul 10, 2026
Jun 26, 2026
8-K items 3.01, 8.01, 9.01
Listing warning from its exchange; Other event · Current report
Jun 24, 2026
Aug 18, 2025
8-K items 1.01, 3.02, 9.01
Major agreement signed; Shares sold without registration · Current report
Aug 15, 2025
Jun 23, 2025
8-K items 5.02, 5.07, 9.01
Officer or director change; Shareholder vote · Current report
May 2, 2025
8-K items 3.03, 5.02, 5.08, 8.01, 9.01
Change to shareholders' rights; Officer or director change; item 5.08; Other event · Current report
Apr 30, 2025
40 of 258 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.